Vascular oligonucleotide transfer facilitated by a polymer-coated stent

Human Gene Therapy

Volumn 16, Issue 6, 2005, Pages 734-740

  Radke, Peter W ^a,b   Griesenbach, Uta ^a   Kivela, Antti ^c   Vick, Terry ^d   Judd, Diane ^a   Munkonge, Felix ^a   Willis, Sean ^d   Geddes, Duncan M ^a   Yla Herttuala, Seppo ^c   Alton, Eric W F W ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d BIOCOMPATIBLES UK LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGONUCLEOTIDE; PHOSPHORYLCHOLINE; POLYMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; CORONARY STENT; DRUG DELIVERY SYSTEM; EX VIVO STUDY; GENE TRANSFER; GENETIC TRANSFECTION; IN VIVO STUDY; MALE; NONHUMAN; PROTEIN TRANSPORT; RABBIT; STENT;

ANIMALS; AORTA; BLOOD VESSELS; COATED MATERIALS, BIOCOMPATIBLE; FLUORESCEIN-5-ISOTHIOCYANATE; GENE TRANSFER TECHNIQUES; KIDNEY; MALE; NF-KAPPA B; OLIGONUCLEOTIDES; PHOSPHORYLCHOLINE; RABBITS; STENTS; TRANSFECTION;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 20844437936     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2005.16.734     Document Type: Article

References (21)

1. BARNES, P.J., and KARIN, M. (1997). Nuclear factor-kappaB: a pivotal transcripition factor in chronic inflammatory diseases. N. Engl. J. Med. 336, 1066-1068.
2. FISCHMAN, D.L., LEON, M.B., BAIM, D.S., SCHATZ, R.A., SAVAGE, M.P., PENN, I., DETRE, K., VELTRI, L., RICCI, D., NOBUYOSHI, M., CLEMAN, M., HEUSER, R., ALMOND, D., TEIRSTEIN, P.S., FISH, R.D., COLOMBO, A., BRlNKER, I., MOSES, I., SHAKNOVICH, A., HIRSHFELD, I., BAILEY, S., ELLIS, S., RAKE, R., GOLDBERG, S., FOR THE STENT RESTENOSIS STUDY INVESTIGATORS. (1994). A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N. Engl. J. Med. 331, 496-501.
3. GRENADIER, E., ROGUIN, A., HERTZ, I., PELED, B., BOULOS, M., NIKOLSKY, E., AMIKAM, S., KERNER, A., COHEN, S., and BEYAR R. (2002). Stenting very small coronary narrowings (<2 mm) using the biocompatible phosphorylcholine-coated coronary stent. Catheter. Cardiovasc. Interv. 55, 303-308.
4. GUNN, J., and CUMBERLAND, D. (1999). Stent coatings and local drug delivery. Eur. Heart J. 20, 1693-1700.
5. HELDMAN, A.W., CHENG, L., JENKINS, G.M., HELLER, P.F., KIM, D.W., WARE, M., Jr., NATER, C., HRUBAN, R.H., REZAI, B., ABELLA, B.S., BUNGE, K.E., KINSELLA, J.L., SOLLOTT, S.J., LAKATTA, E.G., BRINKER, J.A., HUNTER, W.L., and FROEHLICH, J.P. (2001). Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis. Circulation 103, 2289-2295.
6. KEREIAKES, D.J. (2003). Hippocrates revisited: the evidence for drug-eluting stents. Circulation 107, 3012-3014.
7. KLUGHERZ, B.D., JONES, P.L., CUI, X., CHEN, W., MENEVEAU, N.F., DEFELICE, S., CONNOLLY, J., WILENSKY, R.L., and LEVY, R.J. (2000). Gene delivery from a DNA controlled-release stent in porcine coronary arteries. Nat. Biotechnol. 18, 1181-1184.
8. KOMATSU. R., UEDA, M., NARUKO, T., KOJIMA, A., and BECKER, A.E. (1998). Neointimal tissue response at sites of coronary stenting in humans: Macroscopic, histological, and immunohistological analysis. Circulation 98, 224-233.
9. KORNOWSKI, R., HONG, M.K., TIO, F.O., BRAMWELL, O., WU, H., and LEON, M.B. (1998). In-stent restenosis: Contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J. Am. Coll. Cardiol. 31, 224-230.
10. LEWIS, A.L., CUMMING, Z.L., GOREISH. H.H., KIRKWOOD, L.C., TOLHURST, L.A., and STRATFORD, P.W. (2001). Crosslinkable coatings from phosphorylcholine-based polymer. Biomaterials 22, 99-111.
11. LIISTRO, F., and COLUMBO, A. (2001). Late acute thrombosis after Paclitaxel eluting stent implantation. Heart 86, 262-264.
12. NAKAJIMA, T., KITAJIMA, I., SHIN, H., TAKASAKI, I, SHIGETA, K., ABEYAMA, K., YAMASHITA, Y., TOKIOKA, T., SOEJIMA, Y., and MARUYAMA, I. (1994). Involvement of NF-kappa B activation in thrombin-induced human vascular smooth muscle cell proliferation. Biochem. Biophys. Res. Commun. 204, 950-958.
13. PALMER, R.R., LEWIS, A.L., KIRKWOOD, L.C., ROSE, S.F., LLOYD, A.W., VICK, T.A., and STRATFORD, P.W. (2004). Biological evaluation and drug delivery application of cationically modified phospholipid polymers. Biomaterials 25, 4785-4796.
14. PEPINE, C.J., and HOLMES, D.R., Jr. (1996). Coronary artery stents: ACC Expert Consensus Document. J. Am. Coll. Cardiol. 28, 782-794.
15. SERRUYS, P.W., DE JAEGERE P., KIEMENEIJ, F., MACAYA, C., RUTSCH, W., HEYNDRICKX, G., EMANUELSSON, H., MARCO, J., LEGRAND, V., MATERNE, P., BELARDI, J., SIGWART, U., COLOMBO. A., GOY, J.J., VAN DEN HEUVEL, P., DELCAN, J., MOREL. M.-A., FOR THE BENESTENT STUDY GROUP. (1994). A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary heart disease. N. Engl. J. Med. 331, 489-495.
16. TAKAHASHI A, PALMER-OPOLSKI, M., SMITH, R.C., and WALSH, K. (2003). Transgene delivery of plasmid DNA to smooth muscle cells and macrophages from a biostable polymer-coated stent. Gene Ther. 10, 1471-1478.
17. VAN DER GIESEN, W.J., LINCOFF, A.M., SCHWARTZ, R.S., VAN BEUSEKOM, H.M., SERRUYS, P.W., HOLMES, D.R., Jr., ELLIS, S.G., and TOPOL, E.J. (1996). Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 94, 1690-1670.
18. VIRMANI, R., GUAGLIUMI, G., FARB, A., MUSUMECI, G., GRIECO, N., MOTTA, T., MIHALCSIK, L., TESPILI, M., VALSECCHI, O., and KOLODGIE, F.D. (2004). Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: Should we be cautious? Circulation 109, 701-705.
19. WHELAN, D.M., VAN DER GIESSEN, W.J., KRABBENDAM, S.C., VAN VLIET, E.A., VERDOUW, P.D., SERRUYS, P.W., and VAN BEUSEKOM, H.M. (2000). Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries. Heart 83, 338-345.
20. YOSHIMURA, S., MORISHITA, R., HAYASHI, K., YAMAMOTO, K., NAKAGAMI, H., KANEDA, Y., SAKAI, N., and OGIHARA T. (2001). Inhibition of intimal hyperplasia after balloon injury in rat carotid artery using cis-element "decoy" of nuclear factor-kappaB binding site as a novel molecular strategy. Gene Ther. 8, 1635-1642.
21. ZHENG, H., BARRAGAN, P., CORCOS, T, SIMEONI, J.B., FAVEREAU, X., ROQUEBERT, P.O., GUERIN, Y., and SAINSOUS, J. (1999). Clinical experience with a new biocompatible phosphorylcholine-coated coronary stents. J. Invas. Cardiol. 11, 608-614.